Globe Life Inc. $GL Stock Holdings Boosted by Atria Investments Inc

Atria Investments Inc lifted its position in Globe Life Inc. (NYSE:GL) by 40.0% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 6,665 shares of the company’s stock after buying an additional 1,904 shares during the period. Atria Investments Inc’s holdings in Globe Life were worth $828,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of GL. Assetmark Inc. boosted its stake in Globe Life by 777.8% during the second quarter. Assetmark Inc. now owns 237 shares of the company’s stock valued at $29,000 after buying an additional 210 shares in the last quarter. Spire Wealth Management lifted its holdings in Globe Life by 27.7% in the 2nd quarter. Spire Wealth Management now owns 2,123 shares of the company’s stock valued at $264,000 after acquiring an additional 461 shares during the last quarter. Transcend Capital Advisors LLC acquired a new stake in Globe Life in the 2nd quarter valued at about $207,000. Envestnet Asset Management Inc. boosted its position in shares of Globe Life by 14.0% during the 2nd quarter. Envestnet Asset Management Inc. now owns 98,302 shares of the company’s stock valued at $12,218,000 after purchasing an additional 12,099 shares in the last quarter. Finally, Nisa Investment Advisors LLC boosted its position in shares of Globe Life by 0.5% during the 2nd quarter. Nisa Investment Advisors LLC now owns 34,685 shares of the company’s stock valued at $4,311,000 after purchasing an additional 158 shares in the last quarter. Institutional investors and hedge funds own 81.61% of the company’s stock.

Globe Life Price Performance

Shares of NYSE:GL opened at $132.32 on Friday. The company’s fifty day moving average is $138.21 and its two-hundred day moving average is $130.40. The company has a market cap of $10.72 billion, a P/E ratio of 9.59 and a beta of 0.55. Globe Life Inc. has a 12-month low of $100.27 and a 12-month high of $147.83. The company has a quick ratio of 0.06, a current ratio of 0.06 and a debt-to-equity ratio of 0.43.

Globe Life (NYSE:GL) last issued its earnings results on Wednesday, October 22nd. The company reported $4.81 EPS for the quarter, topping the consensus estimate of $4.54 by $0.27. Globe Life had a return on equity of 22.12% and a net margin of 19.36%.The business had revenue of $1.51 billion during the quarter, compared to analysts’ expectations of $1.52 billion. During the same quarter last year, the firm posted $3.44 earnings per share. Globe Life has set its FY 2026 guidance at 14.600-15.300 EPS. FY 2025 guidance at 14.400-14.600 EPS. Equities analysts expect that Globe Life Inc. will post 13.87 earnings per share for the current fiscal year.

Globe Life Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Monday, January 5th will be paid a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Monday, January 5th. Globe Life’s payout ratio is 7.83%.

Analyst Ratings Changes

A number of analysts recently commented on GL shares. Keefe, Bruyette & Woods boosted their target price on shares of Globe Life from $160.00 to $162.00 and gave the stock an “outperform” rating in a report on Tuesday, October 28th. Cfra Research upgraded shares of Globe Life to a “moderate buy” rating in a research report on Friday, July 25th. Wells Fargo & Company dropped their price target on Globe Life from $172.00 to $170.00 and set an “overweight” rating on the stock in a report on Friday, October 24th. Weiss Ratings reiterated a “buy (b-)” rating on shares of Globe Life in a research report on Wednesday, October 8th. Finally, BMO Capital Markets restated a “market perform” rating and issued a $149.00 target price (up from $114.00) on shares of Globe Life in a report on Wednesday, July 30th. Eight equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $153.56.

Globe Life Company Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.